On 26 October 2022, the Lender and Jacobson Pharma Corporation Limited entered into the Second Amendment Agreement to vary the terms of the Facility Agreement (as amended and supplemented by the Amendment Agreement) by revising the maximum principal amount of the Revised Loan Facility from HKD 82,500,000 to HKD 80,000,000. Save as amended and supplemented by the Second Amendment Agreement, all other terms, conditions and provisions in the Facility Agreement (as amended and supplemented by the Amendment Agreement) shall remain unchanged and shall remain in full force and effect.